JMP Securities Downgrades ARIAD Pharmaceuticals (ARIA) to Market Perform
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
JMP Securities downgraded ARIAD Pharmaceuticals (NASDAQ: ARIA) from Market Outperform to Market Perform.
Shares of ARIAD Pharmaceuticals closed at $9.37 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ARIAD to Host Webcast and Conference Call on Brigatinib Data Presentations at the World Conference on Lung Cancer
- Barclays Downgrades Xcel Energy (XEL) to Equalweight
- ARIAD Pharmaceuticals (ARIA) Full Iclusig Approval, Label Update Incremental Positive - Leerink
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesJMP Securities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!